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Calcium regulation of the human 
mitochondrial ATP-Mg/Pi carrier 
SLC25A24 uses a locking pin 
mechanism
Steven P. D. Harborne1,2, Martin S. King1, Paul G. Crichton1,3 & Edmund R. S. Kunji1
Mitochondrial ATP-Mg/Pi carriers import adenine nucleotides into the mitochondrial matrix and 
export phosphate to the cytosol. They are calcium-regulated to control the size of the matrix adenine 
nucleotide pool in response to cellular energetic demands. They consist of three domains: an N-terminal 
regulatory domain containing four calcium-binding EF-hands, a linker loop domain with an amphipathic 
α-helix and a C-terminal mitochondrial carrier domain for the transport of substrates. Here, we 
use thermostability assays to demonstrate that the carrier is regulated by calcium via a locking pin 
mechanism involving the amphipathic α-helix. When calcium levels in the intermembrane space are 
high, the N-terminus of the amphipathic α-helix is bound to a cleft in the regulatory domain, leading 
to substrate transport by the carrier domain. When calcium levels drop, the cleft closes, and the 
amphipathic α-helix is released to bind to the carrier domain via its C-terminus, locking the carrier in an 
inhibited state.
The ATP-Mg/Pi carrier (APC) is a member of the mitochondrial carrier family of transport proteins1–3. The 
carrier exports phosphate and imports adenine nucleotides, resulting in their net uptake into mitochondria1–3. 
In contrast, the related mitochondrial ADP/ATP carrier catalyzes a strict equimolar ADP/ATP exchange, leaving 
the total pools of adenine nucleotides unaltered4. APC is regulated by cytosolic calcium to control the size of the 
matrix adenine nucleotide pool in response to cellular energetic demands1–3, a fundamental process for cellular 
growth and energy metabolism5.
The impact of APC2 (SCaMC3/SLC25A23) knockouts has been studied in mouse liver6, mouse neuronal 
tissue7,8, and that of an APC3 (SCaMC2/SLC25A25) knockout in a mouse model9. These studies highlighted the 
requirement for adenine nucleotide movement in and out of mitochondria for respiratory function and protec-
tion against calcium-induced permeabilisation of the mitochondrial inner membrane in stress conditions10. In 
a pathophysiological role, overexpression of APC1 can assist cancer cells to evade typical cell death pathways 
by increasing calcium precipitation in the mitochondrial matrix, reducing calcium induced permeabilisation of 
the mitochondrial inner membrane11. Therefore, APCs play an important role in mitochondrial function under 
normal conditions, but also in disease.
The ATP-Mg/Pi carriers have three domains: an N-terminal regulatory domain, a linker loop domain with an 
amphipathic α -helix and a C-terminal mitochondrial carrier domain12. The N-terminal regulatory domain forms 
two pairs of EF-hands fused by one long central α -helix. In the calcium-bound state the amphipathic α -helix 
of the linker loop domain is bound to the hydrophobic cleft of EF-hands 3 and 4, analogous to calmodulin12,13. 
The C-terminal carrier domain is involved in substrate transport across the mitochondrial inner membrane14 
and has the structural fold of mitochondrial carriers. It consists of three homologous sequence repeats15, each 
containing two membrane-spanning α -helices connected by a matrix α -helix16. Based on the identification of a 
conserved central substrate binding site17 flanked by two salt bridge networks on either side16,18, an alternating 
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access mechanism has been proposed for substrate transport through carrier proteins4,19. The regulatory domain 
is located in the intermembrane space, but its position relative to the carrier domain is unknown.
The effect of calcium regulation on the transport activity of APC has been studied in isolated rat liver mito-
chondria20, isolated yeast mitochondria3,21 and more recently in liposomes with reconstituted Arabidopsis 
thaliana APC22,23. Furthermore, the effect of calcium on adenine nucleotide uptake into mitochondria of human 
osteosarcoma cells has been studied in which APC1 (SCaMC1/SLC25A24) is the major isoform11. However, the 
effects of calcium on isolated human APC1 reconstituted into liposomes has not been reported2.
A molecular mechanism of calcium regulation has not been established. A capping and uncapping mechanism 
of calcium regulation of APC has been proposed, in which the entire calcium-free regulatory domain forms a 
lid to block substrate transport, but this mechanism lacks molecular detail13. We have proposed an alternative 
hypothesis based on a canonical EF-hand mechanism, in which the EF-hands close in the calcium-free state and 
release the amphipathic α -helix from the hydrophobic cleft to bind to the carrier domain12.
Here, we have probed the inter-domain interactions of the protein in the calcium-bound and calcium-free 
states by analysing evolutionary coupling data and state-dependent changes in thermostability, allowing us to 
distinguish between side chain interactions important for structure and/or those involved in the regulatory mech-
anism, respectively. The results show that the amphipathic α -helix is bound alternately to the regulatory domain 
or the carrier domain depending on the calcium levels.
Results
Activity, orientation and calcium sensitivity of APC1 in liposomes. To establish an assay for calcium 
regulation of transport, full-length human mitochondrial ATP-Mg/Pi carrier isoform 1 (APC1) was expressed in 
yeast mitochondria, purified and reconstituted into liposomes with an efficiency of ~80% (Supplementary Fig. 1). 
Uptake of radiolabelled ATP was measured in the presence or absence of different combinations of unlabelled 
substrates and effectors (Fig. 1a and b, and Supplementary Fig. 2). In the absence of internal ATP there was 
no discernable ATP uptake, regardless of the external calcium concentration, indicating that an internal coun-
ter substrate is required to complete the catalytic turnover at a detectable rate in this assay (Fig. 1a and b, and 
Supplementary Fig. 2). The highest rate of ATP uptake was observed for proteoliposomes loaded with ATP in the 
presence of external calcium, displaying a specific initial rate of ~100 nmol ATP min−1 mg−1. In the presence of 
EGTA, which removes calcium, the rate of ATP uptake dropped almost to background (Supplementary Fig. 2). 
There was no significant difference in ATP uptake between conditions in which no additional calcium was added 
or in which EGTA was added to the outside of the liposomes, suggesting that buffer exchange through the use of 
a PD10 column reduced calcium contaminations to levels that were unable to activate the carrier. Furthermore, 
there was no significant difference in the specific initial rate of ATP uptake catalysed by APC1 in the presence 
or absence of internal calcium. These results show that calcium-dependent activation could be observed for the 
isolated and reconstituted human APC1, demonstrating that it is fully active. Furthermore, only calcium added 
to the outside of the liposome had an effect on uptake activity suggesting that the regulatory domain is only 
accessible from the outside, and that the protein was reconstituted in an orientation that was predominantly with 
the regulatory domain on the outside of the proteoliposomes (~95%) (Fig. 1a and b, and Supplementary Fig. 2).
The external calcium concentration was titrated against liposome-reconstituted APC1 to study the 
effect on ATP transport and estimate the concentration required to half-maximally activate the protein (see 
Supplementary Fig. 3). However, key components of the assay, such as the lipids, can chelate calcium24, and 
therefore the free calcium concentration was estimated experimentally using a fluorescent calcium probe 
(Supplementary Fig. 3). After correction for bound calcium, the EC50 for free calcium was determined to be 
179 ± 67 μ M (Fig. 1e and Supplementary Fig. 3). The calcium sensitivity of various APC paralogues has been 
reported between 4 and 30 μ M6,11,21, including a study using isolated mitochondria where human APC1 was 
thought to be the major isoform11. However, this is the first time that calcium dependency of ATP transport by 
the human APC1 has been assessed in a reconstituted system, showing that its activity will respond linearly to 
changes in cytosolic calcium concentrations.
Titration of EGTA on the outside of the liposomes, in the presence of 1 mM external calcium, showed that 
APC1 could be completely inactivated by the removal of calcium using EGTA concentrations above 1.5 mM 
(Supplementary Fig. 3). No further inhibition was observed with more EGTA additions, meaning that rates of 
~5–10 nmol [14C]-ATP min−1 mg−1 protein represent the background signal, presumably due to slow leak or 
non-specific binding of the radiolabelled ATP to the liposomes.
In order to assess what type of regulatory effect calcium has on the kinetics of ATP transport catalysed by 
APC1, two different concentrations of calcium were added, one low calcium concentration below the calcium 
EC50 (0.25 mM total calcium) and one high calcium concentration (4 mM total calcium), and the effect on ATP 
transport measured (Fig. 1f and Supplementary Fig. 4). The Vmax for ATP uptake was 194 (± 22) nmol min−1 mg−1 
and 1071 (± 104) nmol min−1 mg−1 at 0.25 and 4 mM total calcium, respectively. Importantly, the apparent Km 
was not significantly different (31 ± 9 μ M and 29 ± 8 μ M at 0.25 mM and 4 mM total calcium, respectively, Fig. 1f), 
demonstrating that the mechanism of calcium regulation is non-competitive with respect to ATP transport, as 
shown before for yeast APC21.
The role of the amphipathic α-helix in calcium regulation. Thermostability assays have previously 
been used to probe conformational changes of mitochondrial carriers by assessing their thermostability in 
different states25–27. Here, they have been applied to determine the differences in thermostability between the 
calcium-bound and calcium-free state of detergent-solubilised APC1. Protein unfolding is monitored with the 
fluorescent dye 7-diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin (CPM) that emits a fluorescent signal 
upon reaction with cysteine residues28. By using a controlled temperature ramp, thermal denaturation of the pro-
tein provides a melting curve, the inflection point of which is taken as the apparent melting temperature (Tm) and 
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used as a relative marker of protein stability26,28. APC1 has four cysteine residues: one in the regulatory domain 
and three in the carrier domain. We observed that residue C15 of the regulatory domain could be labeled with 
polyethylene glycol methyl ether maleimide 2000 Da (PEG-maleimide 2 K) in solution (Supplementary Fig. 5a), 
as labeling was abolished by a C15S mutation (Supplementary Fig. 5b). Therefore, C15 is already exposed in the 
native state before thermal denaturation, giving a raised baseline in the CPM assay (Fig. 1c). Only residues buried 
in the carrier domain were exposed and labeled during the thermal denaturation, thus reporting on the unfolding 
of the carrier domain only. In the absence of calcium, the Tm of APC1 was 9 °C higher than in the presence of 
calcium (Fig. 1c and d). This shift in stability to a higher Tm correlates with the calcium-free condition in which 
APC1 is inactive for substrate transport (Fig. 1c and d). Therefore, the thermostability assay is able to report on 
Figure 1. Transport activity and thermostability of wild-type APC1 in the presence or absence of calcium. 
(a) Uptake of radiolabelled ATP (red) into proteoliposomes measured with different unlabelled internal and 
external substrates and effectors (black). Proteoliposomes were made with 2.5 mM ATP and 1 mM calcium 
chloride (circles), 2.5 mM ATP and 1 mM EGTA (triangles) or no ATP and 1 mM EGTA (squares). Uptake 
was initiated by addition of 1.5 μ M [14C]-ATP to the outside of liposomes. (b) The initial uptake rates in the 
conditions indicated in the table were calculated from the fit of the curves in panel A. (c) Thermostability assays 
with CPM. Purified carrier protein was diluted to 50 μ g mL−1 in assay buffer, and pre-equilibrated CPM was 
added to 1 μ g mL−1. Either 2.5 mM calcium chloride (blue curve) or 2.5 mM EGTA (black curve) was added 
prior to temperature ramping. A sample without protein was included for baseline reference (grey). (d) The 
apparent melting temperature can be derived from the inflection point of the unfolding curve from the first 
derivative. (e) APC1 proteoliposomes loaded with 2.5 mM ATP and uptake of 1.5 μ M [14C]-ATP stimulated 
by the addition of 0, 0.05, 0.1, 0.5, 1, 2, 3 or 4 mM calcium chloride on the outside. Free calcium concentration 
was determined against a standard curve in the presence of 1 μ M of fluo-5N (Supplementary Fig. 3). The 
relationship between initial ATP uptake rate and the calcium concentration was plotted using specific initial 
rates (Supplementary Fig. 3) and fitted with a curve describing hyperbolic saturation kinetics. (f) Uptake from 
APC1 proteoliposomes loaded with 2.5 mM ATP, with increasing concentrations of ATP (1.5, 6, 12, 20, 38, 
60, 80 and 100 μ M) added to the outside and in the presence of either 0.25 mM or 4 mM calcium chloride. 
The Michaelis-Menten relationship between initial ATP uptake rate (Supplementary Fig. 4) and the ATP 
concentration was plotted for 0.25 mM (filled squares) and 4 mM (open squares) concentrations of external 
calcium using the specific initial rates. Error bars represent standard deviation for measurements taken from 
three independent liposome preparations.
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changes in stability of the carrier domain associated with calcium-induced activation or inhibition by the regu-
latory domain.
Previous analysis of the regulatory domain indicated that the amphipathic α -helix is a mobile element that 
binds to the regulatory domain in the presence of calcium, but might be released in the absence of calcium12. 
We postulate that the amphipathic α -helix interacts with the carrier domain in the calcium-free state in order to 
inhibit substrate transport. To investigate this possibility, a series of N-terminal truncations of the carrier were 
generated where the entire regulatory domain was removed, but where different parts of the linker region were 
still present. Truncation mutant ∆ 1-155 retains the amphipathic α -helix and linker loop, ∆ 1-171 retains just 
the linker loop, and ∆ 1-191 has no linker region at all (Fig. 2a). In all of the truncations, the calcium-dependent 
increases in Tm observed for wild-type APC1 were abolished (Fig. 2b). Instead, the truncation mutants ∆ 1-171 
and ∆ 1-191 were slightly destabilised in the calcium-free condition, which may be a direct effect of EGTA on 
the stability of the carrier domain. Truncation mutant ∆ 1-155 APC1, which lacked only the regulatory domain, 
displayed a remarkable increase in Tm to 75.0 °C in the presence or absence of calcium (Fig. 2b). Proteoliposomes 
made with ∆ 1-155 truncation mutant did not display ATP uptake, whether calcium was present or not, indicating 
that this protein was constitutively inactive (Fig. 2c).
The ∆ 1-171 and ∆ 1-191 truncation mutants had stabilities of 56.7 and 47.5 °C in the presence of calcium, 
respectively, showing that ∆ 1-171 was equally and ∆ 1-191 was less stable than wild type in the presence of cal-
cium. These results show that the amphipathic α -helix is the main contributor to the high thermostability of the 
∆ 1-155 truncation mutant by interacting with the carrier domain and that the linker loop region provides inter-
actions stabilising the carrier domain (see also below). Based on the thermostabilities of the ∆ 1-171 and ∆ 1-191 
truncation mutants, we expected that both would be active, and indeed, in the presence of calcium, proteolipos-
omes made with ∆ 1-171 or ∆ 1-191 APC1 displayed ATP uptake activity, albeit to a lower level than the wild-type 
protein, which might be due to stability issues during reconstitution (Fig. 2c). Uptake of ATP by these truncation 
mutants was almost abolished in the presence of EGTA (Fig. 2c), which was surprising as the regulatory domain 
was missing. In order to understand this effect, ATP uptake was measured in ∆ 1-191 APC1 proteoliposomes 
in the presence of saturating conditions (5 mM) of magnesium chloride, calcium chloride or EGTA on the out-
side, in exchange for ADP loaded on the inside (we suspected that calcium was being transported). Without the 
addition of divalent cations to the outside of liposomes, the specific initial uptake rate of ATP was low (~5 nmol 
min−1 mg−1 protein; Fig. 2d). This low rate of ATP for ADP exchange was not due to the build-up of membrane 
potential (Supplementary Note 1 and Supplementary Fig. 6). The specific initial uptake rate of ATP was highest in 
the presence of externally added magnesium, increasing six-fold to ~30 nmol min−1 mg−1 protein (Fig. 2d). The 
addition of calcium also increased the specific initial uptake rate of ATP three-fold to ~15 nmol min−1 mg−1 pro-
tein (Fig. 2d), consistent with significant transport of ATP-Ca. Therefore, we concluded that the inhibitory effect 
of EGTA was due to the fact that free ATP is transported at much lower rates than ATP-Ca23 (see Supplementary 
Note 1 and Supplementary Fig. 6).
Our results refute the ‘capping mechanism’ involving the whole regulatory domain, as proposed previously13, 
which would predict full activity of ∆ 1-155 APC1. Instead these results demonstrate that the amphipathic α -helix 
is the key regulatory element, interacting with the carrier domain to inhibit substrate transport when released 
from the regulatory domain. We have named this a locking pin mechanism, as the amphipathic α -helix acts as a 
pin that is released by the regulatory domain in the absence of calcium, to bind and lock the carrier domain in an 
inhibited state.
A structural model for the entire calcium-bound human ATP-Mg/Pi carrier. To understand the 
mechanism of calcium regulation in molecular detail, we constructed a model of the entire APC1 protein. A 
crystal structure of the calcium-bound regulatory domain12,13, and structural models of the calcium-free reg-
ulatory domain12 and carrier domain, based on the ADP/ATP carrier structures16,19, were available. However, 
a reference structure for the loop region of the protein between the regulatory and carrier domains (residues 
171–191) was not, and so the position and orientation of the regulatory domain relative to the carrier domain 
was unknown. To aid model building we used the established bioinformatic method of evolutionary coupling 
analysis29. Evolutionary variation between APC orthologues was used to determine residue pairs that have 
co-evolved together because they might be spatially close to and/or interacting with one another. These resi-
due pairs can be used as distance constraints for modeling. In total 470 potential interactions were provided 
by the EVfold server29, but we found that interactions with a pseudo-likelihood maximization score (PLM) 
below 0.2 could not be confirmed by the available structures or displayed spuriously large interaction distances 
(Supplementary Fig. 7 and Supplementary Table 1). Therefore, we restricted our analysis to EVcoupling pairs 
with PLM scores above 0.2, allowing us to build a network of interactions that were used as distance constraints 
in modeling (Supplementary Fig. 8 and Supplementary Table 2).
Many of the EVcoupling pairs could be confirmed in the available structural models, supporting the valid-
ity of the approach. Two evolutionary coupled pairs of residues (K96:N102 and N34:E43) were located in the 
regulatory domain, and their relative positions and interactions could be confirmed in the crystal structure 
(Supplementary Fig. 8c and d)12. Another four of the evolutionary coupled pairs of residues were located in the 
carrier domain (I435:L443, E438:R445, F238:L250 and F238:V424), and these interactions were consistent with 
the comparative homology model of the carrier domain (Supplementary Fig. 8e and f)16. The remaining 14 inter-
acting pairs were located at the end of the amphipathic α -helix, in the linker-loop and at the N-termini of the first 
transmembrane helix of the carrier domain. The constraints supplied by the evolutionary coupling data allowed 
us to construct a model for the linker-loop region (Supplementary Fig. 8a and b). We noted that there were no 
co-evolved pairs between the regulatory domain and the carrier domain (Supplementary Fig. 8). Thus it appears 
that the regulatory domain interacts with the carrier domain via the linker-loop region, which would allow both 
domains to move independently of each other. It also shows that the linker-loop region is a key component of the 
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Figure 2. Thermostability and transport properties of wild-type and ∆1-155, ∆1-171 and ∆1-191 
truncation mutants of APC1. (a) Cartoon representation of the tested truncation mutants. The amphipathic α 
-helix and linker-loop (residues 155-191) are indicated in red. (b) The apparent melting temperatures (app. Tm) 
determined in the presence of 2.5 mM calcium chloride or EGTA, added prior to temperature ramping. (c) The 
specific initial uptake rate of 1.5 μ M [14C]-ATP into proteoliposomes, containing wild-type, ∆ 1-155, ∆ 1-171 
or ∆ 1-191 truncation mutants. The inside contained 2.5 mM ATP only (without calcium or EGTA), whereas 
on the outside there was 1.5 μ M [14C]-ATP and 2.5 mM calcium chloride or 2.5 mM EGTA. (d) The N-terminal 
truncation (∆ 1-191_APC1) construct was reconstituted into liposomes and the amount of 1.5 μ M [14C]-ATP 
taken up, measured. All liposomes were loaded with 2.5 mM ADP, 1 mM DTT and 20 mM tris-HCl pH 7.4. 
Either 5 mM magnesium chloride, 5 mM calcium chloride or 5 mM EGTA was added to the outside of the 
liposome, and hetero-exchange between ATP and ADP was monitored over a 15-minute time course. Specific 
initial rates were fitted and significance values were calculated using unpaired, two-tailed Student’s t-tests, 
where; NS p > 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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overall structural stability of the transporter in agreement with the truncation analysis (Fig. 2). Given the lack of 
constraints, it was not possible to determine the lateral position of the regulatory domain relative to the carrier 
domain, but the constraints provided by the compact linker-loop domain did restrain the orientation of the reg-
ulatory domain relative to the carrier domain. A number of regulatory domain positions were modeled, and the 
highest scoring one was used, but all are in agreement with the locking pin mechanism (Supplementary Fig. 8a 
and b).
State-dependent thermostability shifts in ATP-Mg/Pi carrier mutants. Next we set out to inves-
tigate the role of specific residues to probe the molecular detail of the locking pin mechanism. We were par-
ticularly interested in residues of the amphipathic α -helix, the regulatory domain and the cytoplasmic side of 
the carrier domain. As the mechanism of calcium regulation is likely to be universally conserved across ortho-
logues, we selected conserved residues for mutagenesis by inspecting sequence alignments of APC orthologues 
(Supplementary Fig. 9). Charged residues of the carrier and regulatory domain that are conserved in more than 
50% of the orthologues were selected, but those playing a role in calcium binding12,13 or substrate transport17,18 
were excluded, leaving a set of 14 residues (Supplementary Fig. 9). All 14 residues of the amphipathic α -helix 
were also selected for mutation. Thus, in total 28 single alanine replacements were made and all of the mutant 
full-length carriers were expressed in yeast mitochondria, solubilised and purified. The thermostability of the 
mutant proteins was analysed in the presence or absence of calcium (Fig. 3a). In all cases, typical sigmoidal melt-
ing profiles were obtained, confirming the presence of folded protein and allowing Tm values to be determined 
(Fig. 3a).
To interpret these results, the Tm of wild-type was subtracted from the Tm of each mutant, providing a relative 
difference in melting temperature (Δ Tm) in both the calcium-bound (active) and calcium-free (inactive) states. 
The differences in the presence of calcium were plotted against those in the presence of EGTA (Fig. 3b). Mutations 
with a similar effect on thermostability in both the calcium-bound and calcium-free states point to residues that 
are equally important for protein stability in both states, indicating a similar structural role in both conditions 
(black diagonal line - Fig. 3b). Mutations that affected the thermostability in one state more than the other point 
to residues that are likely to be involved in calcium regulation. In Fig. 3b, these mutants are shifted to the red 
parallel line, which represents the position of thermostabilities with a complete absence of calcium-dependent 
changes, i.e. a loss of the ~9 °C difference in thermostability between the calcium-bound and calcium-free state, 
as observed for the wild-type protein (Fig. 1a and d). Mutations with similar effects clustered into four distinct 
groups (colored dashed rings in Fig. 3b).
Figure 3. Effect of mutations on the thermostability of APC1. (a) Effect of mutations on the apparent 
thermostability of APC1. The apparent melting temperatures of 28 alanine replacement mutants were 
determined by using the CPM thermostability assay. Either 2.5 mM calcium chloride (light gray bars) or EGTA 
(dark gray bars) were added to the sample 10 minutes before temperature ramping. (b) The difference in Tm of 
each mutant from the Tm of wild-type APC1 was calculated. For each mutant, the ∆ Tm in the calcium condition 
was plotted against the ∆ Tm in the EGTA condition. Mutations that have a similar effect on stability to one 
another in both the presence and absence of calcium cluster together on the graph, and have been grouped 
accordingly with a colored line. Mutations on the diagonal line (black dashed line) have a proportional effect on 
stability in the presence and absence of calcium. Mutations on the parallel line (red dashed line), shifted by 9 °C 
relative to the wild-type, have a disproportional effect on stability in one condition over the other, indicating an 
effect on regulation.
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Representative members of the four clusters were assessed for their ability to transport substrates in both 
the presence and absence of calcium. Mutations at D158 (no cluster), E161 (cyan cluster) and K277 (grey clus-
ter) responded to calcium and EGTA in a similar way to wild-type, however, mutations at E88 and I159 (blue 
cluster) resulted in a significantly lower uptake activity in the presence of calcium in comparison to wild-type 
(Supplementary Fig. 10). Uptake assays were attempted on the D176A, E183A and R291A mutants (green clus-
ter), but their transport properties could not be determined, because their overall thermostability was much lower 
than that of the wildtype and blue cluster mutants (Fig. 3a), which lead to stability issues during reconstitution.
Role of individual residues in the mechanism of calcium regulation. The blue and green clusters of 
mutants must be important for the regulatory mechanism, but they differ fundamentally from each other in the 
way the mutations affect the thermostability. The blue cluster is predominantly affected in the calcium condition, 
being ~9 °C more stable (vertical shift), whereas the green cluster is predominantly affected in the EGTA condi-
tion, being ~9 °C less stable (horizontal shift) (Fig. 3b). Accordingly, the blue cluster mutants should be shifted 
towards a constitutively inactive state, while the green cluster mutants should be shifted toward a constitutively 
active state. The transport activity of the blue cluster mutants I159A and E88A in the presence of calcium corre-
lated inversely with their thermostability shift; the more the residue stabilised the calcium-bound state, the bigger 
the inactivation of transport upon mutation (i.e. mutations further up the red dashed line are those most impaired 
in regulatory activity; Supplementary Fig. 10), consistent with an increased likelihood of amphipathic α -helix 
release, which leads to inhibition of the carrier.
In order to interpret the role of each cluster of mutants, their structural positions were mapped on to a model 
of the calcium-bound APC1 (Fig. 4a and b). The mutations E88A, R148A and D149A of the blue cluster have 
similar effects on stability (Fig. 3b), and they are close in the structure of the regulatory domain12, forming a 
salt-bridge network, which we have named the ‘ERD-clasp’ (Fig. 5a). Similarly, mutations T157A, E161A, I162A 
and F165A of the cyan cluster are also close to each other in the regulatory domain12, but are at the N-terminus of 
the amphipathic α -helix (Fig. 5a). In descending order, mutations at residues I159, E88 and R148 display the larg-
est thermostability shifts from wild-type (Fig. 3b) and, when tested, they display an impairment in ATP uptake 
that correlates with the severity of the thermostability changes (Supplementary Fig. 10). Therefore, all of these 
residues play an important role in stabilising the active state of the protein, because they are involved in binding of 
the amphipathic α -helix to the regulatory domain in agreement with the available structural information.
The results above show that residues that are close to one another, performing a similar structural/functional 
role, cluster together in the thermostability shift assays. The residues of the green cluster show behavior we would 
expect for those involved in the calcium-free inactive state of the protein when the amphipathic α -helix inter-
acts with the carrier domain. Residues W166, K167, D176, and E183 (green cluster in Fig. 3b) are all found at 
the C-terminal end of the amphipathic α -helix and linker-loop (Fig. 5b). Residue R291, which is located in the 
carrier domain, gave a similar effect on thermostability in the calcium-free state as residues D176 or E183 of the 
amphipathic α -helix, and it is possible that it interacts with them in the inhibited state.
Mutations with a similar effect on thermostability in both the calcium-bound and calcium-free states are 
residues that are equally important for protein stability in both conditions, indicating that they are not involved 
in regulation. Mutations of residues E160, R164, H168, S169, T170, D173, D182, R196 and N382 (grey cluster in 
Fig. 3b) belong to this category and are located at the end of the amphipathic α -helix, throughout the linker-loop 
Figure 4. Positions of the 28 alanine replacements mapped to the APC1 model. (a) View from the 
membrane and (b) view from the cytoplasmic side of the APC1 model. The mutations are shown as spheres and 
they are colored according to clusters identified in Fig. 3b. The regulatory domain (blue) is based on the APC1 
regulatory domain crystal structure (PDB: 4ZCV)12. The carrier domain (grey) is a comparative homology 
model based on the crystal structure of bovine AAC (PDB: 1OKC)16,49. The linker-loop structure is based on 
evolutionary coupling data (Supplementary Fig. 8 and Supplementary Table 2).
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and at the cytoplasmic side of the carrier domain (Fig. 4a and b). These residues were independently positioned 
close to one another in our model based on evolutionary coupling (Fig. 5c), showing again consistency between 
the evolutionary coupling and thermostability data. It is likely that the residues in the grey cluster are involved in 
stabilising interactions important for the structural integrity of the protein, forming a folded domain between the 
regulatory domain and carrier domain.
Residue D158 appears to be an outlier in the thermostability shifts (Fig. 3). This residue is not conserved, 
and the level of inhibition was not significantly different from that of the wild-type in transport experiments 
(Supplementary Fig. 10). Furthermore, this residue is not involved in any interactions with the regulatory domain 
in the calcium-bound regulatory domain crystal structure of APC112. Therefore, D158 may be involved in the 
regulatory mechanism, but we cannot assign a role for it.
Proposed conformational changes between the calcium-bound and calcium-free states. Based 
on all of our results, we have constructed a model for the calcium-free state of APC1 and propose a confor-
mational change between the two states (Fig. 6 and Supplementary Movie 1). In this calcium-free model, the 
EF-hands of the regulatory domain are closed, excluding the amphipathic α -helix from its hydrophobic binding 
pocket in the regulatory domain12. Instead, the amphipathic α -helix interacts with residues of the cavity in the 
carrier domain, inhibiting its function (Fig. 6). In the calcium-bound model, the residues of the blue cluster are 
close to one another and engaged in bonding interactions, facilitating the locking of the amphipathic α -helix into 
its hydrophobic binding pocket in EF-hands 3 and 4, and allowing the carrier domain to be active. The amphipa-
thic α -helix is released in the calcium-free state and these residues are no longer close to one another (Fig. 6). In 
contrast, residues of the green cluster are far apart in the calcium-bound model, but move closer together when 
the amphipathic α -helix binds to the carrier domain (Fig. 6).
Discussion
Normally EF-hand mechanisms involve the binding of an amphipathic α -helix in a target polypeptide by a 
calcium-bound EF-hand, propagating downstream signaling events30. Here, the locking pin mechanism shares 
features of this mechanism, but differs also, as the regulatory amphipathic α -helix and EF-hands are part of the 
same polypeptide chain. It represents an interesting example of evolution in which different domains have been 
combined in order to regulate substrate transport. There are other examples of EF-hand-containing proteins 
that have this type of ‘self-sequestered’ interaction31–34, but only the mitochondrial aspartate/glutamate carrier 
(AGC) has a similar combination of domains35. AGC also displays a calcium-dependent stimulation of activity 
in its carrier domain36,37 when calcium binds to its EF-hand containing N-terminal regulatory domain35. Even 
so, APC and AGC do not share significant sequence similarity in their regulatory domains; APC has canonical 
EF-hand motifs like calmodulin, whereas AGC contains S100-like calcium-binding motifs12,35. In addition, the 
AGC regulatory domain contains a dimerisation interface for the formation of homo-dimers35, whereas APC is 
Figure 5. Interactions between residues highlighted by the thermostability shift assays. Detailed views 
of residues of (a) the blue and cyan clusters, (b) the green cluster and (c) the grey cluster of mutants (Fig. 3b). 
Possible hydrogen bond interactions are displayed as dotted black lines. The entire APC1 model has been 
constructed as explained in Supplementary Fig. 8.
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monomeric12. Furthermore, in AGC the carrier domain is inserted between the EF-hands and the target α -helix, 
whereas in APC the target α -helix is inserted between the EF-hands and the carrier domain. The proposed regu-
latory mechanism of AGC involves rotation of a mobile unit of EF-hands 1–2 against the static unit of EF-hands 
4–8 of the regulatory domain to close access to the carrier domain35. Here, we show that the regulatory mecha-
nism of APC is fundamentally different in which EF-hands have evolved in a unique way to regulate substrate 
transport by a locking pin mechanism.
Methods
Sequence alignment. The Basic Local Alignment Search Tool38 was used to search for orthologues of either 
the Saccharomyces cerevisiae or Homo sapiens APC sequences. Over 300 unique APC sequences of putative APC 
orthologues from a diverse range of mammalian, invertebrate, plant and fungal species were collated. Initial 
alignment between the sequences was carried out using ClustalW39. Representative sequences from each phy-
logenetic clade were selected for manual alignment and refinement. In this way the list of sequences was manually 
curated to produce a core set of ~30 aligned sequences that accurately represent the conservation and diversity 
of APC sequences across all phyla. The sequence alignment combined with secondary structure prediction tools 
(PSIPRED)40 were used in order to predict the secondary structure elements.
Cloning and mutagenesis. A construct of APC1 (Uniprot: Q6NUK1) was designed to include an 
eight-histidine tag followed by a Factor Xa cleavage site (IEGR) at the N-terminus, creating a cleavable 
purification-tag. The gene was codon-optimised for expression in S. cerevisiae (GenScript, Piscataway, USA) 
and cloned into a pYES3/CT expression plasmid (Invitrogen, Paisley, UK), with the inducible galactose pro-
moter replaced by the constitutive promoter for the yeast mitochondrial phosphate carrier by a method described 
previously41.
The method of overlap extension PCR was used in order to introduce 28 specific point mutations into the 
APC1 gene sequence42. Three truncations of the HsAPC-1 construct were also prepared utilising three different 
forward primers for the ∆ 1-155 t ru nc at ion ( GA AT TC AA CA TG TC TC AC CA CC AC CA CC AC CA CC AC CA CT 
CC GA CG CC GC CA TA GA AG GT AG AA CC TC CGAAGATGTTACTGATATCGAAGAAATCATCAG), the ∆­ 
1-171 truncation ( GA AT TC AA CA TG TC TC AC CA CC AC CA CC AC CA CC AC CA CT CC GA CG CC GC CA TA G
A AG GT AG AA CC TC CGAAGATGGTATTGATATAGGTGACAGTTTAAC) and the ∆ 1-191 truncation ( GA
ATTCAACATGTCACATCACCATCATCATCATCATCACTCAGATGCTGCTATTGAAGGTCGTACATCA
GAAGATTCTGGTCAATGGTGGAGACAATTGTTAGC), and all truncations used the same reverse primer 
(CCTAGGTCTAGACTCGAGTCA). The wild-type APC1, mutant and truncated constructs were ligated into 
the expression plasmid and then transformed into S. cerevisiae haploid strain W303-1b43, using established 
methods44.
Expression in yeast. S. cerevisiae was cultured, and the truncated and mutated APC1 were expressed 
following established methods19, with the following modifications: pre-cultures of yeast were set up in 
synthetic-complete tryptophan-dropout medium (Formedium, Hunstanton, UK) supplemented with 2% glucose, 
and main cultures were carried out in 10 × 2.5 L full-baffle TunAir® shake flasks (Sigma-Aldrich, Gillingham, 
UK) with 1 L of YPD medium in each. Mitochondria were prepared using established methods45, flash frozen in 
liquid nitrogen, and stored under liquid nitrogen until use.
Figure 6. Role of the amphipathic α-helix in the proposed locking pin mechanism of calcium regulation. 
View from the membrane of the (a) calcium-bound or (b) calcium-free states of the APC1 model. The calcium-
bound regulatory domain in blue is based on PDB: 4ZCV. Residues of the blue and green clusters are displayed 
as colored spheres, representing the Cα atoms. Known (a) and predicted (b) interactions between residues 
in the different states have been indicated with dashed black lines. The calcium-free regulatory domain is 
based on a model in which all EF-hands of the regulatory domain are closed12. The carrier domain in grey is 
a comparative model based on the bovine AAC crystal structure (PDB: 1OKC)16. The amphipathic α -helix is 
shown in red. The α -helices are represented as cylinders. The substrates ATP-Mg and phosphate, and activating 
calcium ions are in sphere representations.
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Solubilisation and purification. For the purification of wild-type, mutant and truncated APC1, the pro-
tein was solubilised in 1.5% lauryl maltose neopentyl glycol (1 hour, 4 °C), and separated from insoluble protein 
by centrifugation (182,000 × g, 1 hour, 4 °C). Solubilised protein was then passed through nickel sepharose affin-
ity resin (GE Healthcare, Little Chalfont, UK) at 1 mL min−1 (ÄKTA prime, 4 °C) to selectively bind APC1. The 
affinity resin was washed with 50 column volumes of buffer A (20 mM tris-HCl, pH 7.4, 150 mM sodium chloride, 
20 mM imidazole, 0.1% (w/v) lauryl maltose neopentyl glycol, 0.1 mg mL−1 tetraoleoyl cardiolipin) and 30 col-
umn volumes of buffer B (20 mM tris-HCl, pH 7.4, 50 mM sodium chloride, 0.1% (w/v) lauryl maltose neopentyl 
glycol, 0.1 mg mL−1 tetraoleoyl cardiolipin). 120 units of factor Xa protease (New England Biolabs, Ipswich, USA) 
was used to specifically cleave APC1 protein from the affinity resin (18 hours, 4 °C). After factor Xa cleavage, 
APC1 was spun (1,000 × g, 3 minutes, 4 °C) through an empty Proteus midi-spin column (Generon, Maidenhead, 
UK) to remove affinity resin.
Reconstitution. The lipids L-α -phosphatidylcholine (Avanti Polar Lipids, Alabaster, USA) and tetraoleoyl 
cardiolipin (Avanti Polar Lipids, Alabaster, USA) were mixed in a 20:1 (w/w) ratio and dried under a stream of 
nitrogen. Lipids were washed once with methanol before being dried once again in a stream of nitrogen. Lipids 
were re-hydrated in 20 mM tris-HCl pH 7.4, 1 mM DTT to a final lipid concentration of 12 mg mL−1. Cold sub-
strates or effectors to be internalised into the interior of liposomes were added at this point as concentrated stocks. 
2% (v/v) of the detergent pentaethylene glycol monodecyl ether was added and the lipids were solubilised by 
vortexing. Protein was added to the sample in a 100:1 (w/w) ratio, lipid to protein, diluting the protein 10-fold to 
a concentration of 0.1 mg mL−1. The samples were then incubated with inversion at 4 °C for one hour. The penta-
ethylene glycol monodecyl was removed, and liposomes formed by SM-2 bio-bead (Bio-Rad, Hemel Hempstead, 
UK) additions. Eight additions of bio-beads were made to the sample, the first four of 60 mg, and the final four 
of 120 mg. Between additions, the samples were incubated with inversion at 4 °C for 20 min each. Following the 
final bio-bead addition the samples were incubated overnight at 4 °C with inversion. Bio-beads were removed by 
passage of the sample through empty micro-bio spin columns (Bio-Rad, Hemel Hempstead, UK). The external 
buffer was replaced with 20 mM tris-HCl pH 7.4 using a PD10 desalting column (GE Healthcare, Little Chalfont, 
UK), taking care to prevent carry over of cold substrates or effectors. The sample was diluted with assay buffer for 
a final lipid concentration of 1 mg mL−1.
Uptake assays. Uptake assays were carried out using a Hamilton MicroLab Star robot (Hamilton Robotics 
Ltd., Birmingham, UK). Uptake of radiolabeled ATP was initiated at room temperature (20 °C) by the addition 
of 100 μ L 20 mM tris-HCl, pH 7.4 buffer with 1.5 μ M [14C]-ATP (2.035 GBq mmol−1; Moravek, Brea, USA) to 
100 μ L of liposomes plus effectors (calcium, magnesium or EGTA) in a MultiScreenHTS-HA 96-well filter plate 
(pore size, 0.45 μ m; Millipore, Billerica, USA). The transport was stopped at 0, 10, 20, 30, 45 s, 1, 2.5, 5, 7.5, 10 and 
15 min by the addition of 200 μ L ice-cold 20 mM tris-HCl buffer and filtering using a vacuum manifold, followed 
by an additional wash step with 200 μ L ice-cold 20 mM tris-HCl, pH 7.4 buffer. Levels of radioactivity in the lipos-
omes were measured by the addition of 200 μ L MicroScint-20 (Perkin Elmer, Waltham, USA) and by quantifying 
the amount of radioactivity with the TopCount scintillation counter (Perkin Elmer, Waltham, USA). Specific 
initial uptake rates were calculated using the amount of protein loaded into the liposome, which was quantified 
by SDS-PAGE. In the assays the final concentration of lipid and protein was 0.5 mg mL−1 and about 25 μ g mL−1 
(but specifically quantified for each sample), respectively.
Curves for each uptake were fitted following a one-phase association relationship in Prism (GraphPad). Initial 
rates were determined from the fit of the entire curve over the 15 minutes. There was a slight delay between the 
addition of radioactive substrate for the zero time point and the washing and vacuuming steps. For this reason 
the value was not constrained to zero during curve fitting, allowing a better fit of the data, and the delay was deter-
mined to be approximately 15 s, consistent throughout the entire series of experiments.
In order to estimate the free calcium concentration in liposome samples where different total calcium con-
centrations had been added, fluorescence readings (ex/em; 494/536 nm) were taken using a Spectramax M2 
(Molecular Devices, Sunnyvale, USA) plate reader after the addition of 1 μ M of the low affinity calcium probe 
fluo-5N (Thermo Fisher Scientific, Waltham, USA). Fluorescent signal was compared to a standard curve at 0.2, 
1, 5, 10, 30, 200, 1000 μ M calcium chloride in 20 mM tris-HCl pH 7.4, and the free-calcium concentration inter-
polated from the fit of the standard curve. Curves were fitted describing hyperbolic saturation kinetics for each 
set of initial uptake rates that had been corrected for free calcium independently providing three independent 
estimates of the Vmax and EC50.
Each N number represents an independent liposome preparation and error bars represent the standard 
deviation between them. Statistical tests were calculated using unpaired, two-tailed Student’s t-tests, where; NS 
P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.
PEG-maleimide assay. 0.6 μ g of either wild-type or C15S APC1 was diluted into 500 μ L of assay buffer 
(20 mM tris pH 7.4, 0.1% lauryl maltose neopentyl glycol, 0.1 mg mL−1 tetraoleoyl cardiolipin). The sample 
was split into two aliquots, and to one, 0.2% (w/v) SDS was added. For a non-labelled sample, 25 μ L from each 
was removed before reaction with polyethylene glycol methyl ether maleimide 2000 kDa (PEG-maleimide 2 K; 
Sigma-Aldrich, Gillingham, UK). A further 25 μ L sample to act as a control for DTT quenching; to which 20 mM 
DTT was added before adding 0.5 mM PEG-maleimide 2 K. For the main reaction, 0.5 mM PEG-maleimide 2 K 
was added to the sample, 25 μ L aliquots taken at 1, 5, 10, 20 and 30 min and quenched immediately with the 
addition of 20 mM DTT. Each of the samples were then mixed with loading buffer and analysed by SDS-PAGE.
Thermostability assays. A fluorescence-based procedure for the assessment of detergent-solubilised and 
purified membrane protein stability was used, following established methods26,28. Briefly, 5 mg mL−1 stocks of 
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7-diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin (CPM) dissolved in DMSO were diluted 50-fold into 
the assay buffer (20 mM tris-HCl pH 7.4, 20 mM NaCl, 0.1 mg mL−1 tetraoleoyl cardiolipin, 0.1% (w/v) lauryl 
maltose neopentyl glycol) and incubated for 10 min at room temperature. For each test, purified protein was 
diluted 50-fold in the same assay buffer (approximately 50 μ g mL−1), and incubated on ice for 10 min in 200 μ L 
thin-walled PCR tubes. 5 μ L of the CPM dilution was added to the sample to make a final volume of 50 μ L and 
incubated on ice for a further 10 min. The samples were subjected to a high-resolution melt (HRM) procedure on 
a Rotor-Gene Q 2plex HRM qPCR cycler with a 36-sample rotor (Qiagen, Venlo, the Netherlands).
In the assay, buried cysteine residues become solvent-exposed as protein unfolds, and react with CPM to form 
fluorescent adducts (ex/em optima of 387/463 nm). Protein unfolding profiles were analysed using the Rotor-gene 
Q software and the peak in the derivative of the fluorescence signal as a function of temperature, the ‘melt’ tem-
perature (Tm), provided a relative measure of protein stability.
Protein analysis. Protein concentrations were determined using the bicinchoninic acid assay46 against a 
bovine serum albumin standard curve (Pierce, Loughborough, UK). The proteoliposomes used for uptake assays 
were loaded onto an SDS-PAGE gel and the protein concentration estimated by comparison to a standard curve 
of APC1 of known concentration. SDS-PAGE gels were composed of 12% acrylamide and run using a tris-glycine 
buffer system. Gels were loaded with 5:1 mix of sample to loading buffer (10% SDS (w/v), 1% bromophenol blue 
(w/v), 50% glycerol (v/v), 500 mM DTT, 250 mM tris-hydrochloride pH 6.8). Gels were stained with Imperial 
coomassie stain (Bio-Rad, Hemel Hempstead, UK) for one hour, and de-stained overnight in water.
APC1 model building. Interacting pairs of co-evolved residues were identified using EVfold web server29. 
In total 1844 APC sequences were identified by the program, aligned and compared using EVfold server default 
options. The program identified 470 possible paired residues, and ranked them using a pseudo-likelihood max-
imisation (PLM) scoring method29. Of these pairs, only those with a PLM score greater than 0.2 were consid-
ered. This was the range in which pairs with known structural positions could be used to validate correctly 
identified evolutionary couples. Of the 20 residue pairs that were considered, 14 were in the linker-loop region 
of unknown structure and five of those were between residues that could form hydrogen bond interactions 
(Supplementary Table 1).
Five possible hydrogen bond interactions between evolutionary coupled residues were used as distance con-
straints in model building (Supplementary Table 1). The I-TASSER web server47 was used to build an initial 
structure of residues 170-193, using specified distances of 3 Å for hydrogen bond interactions. The model that best 
agreed with the distance constraints was used, which predicted a compact structure rather than a fully extended 
loop domain. The distance between the C-terminus of the regulatory domain and the N-terminus of the carrier 
domain could be constrained to the length of a compact linker-loop, providing a relative orientation of the regu-
latory domain to the carrier domain. However, the lateral position of the regulatory domain relative to the carrier 
could not be fixed. Many possible poses of the regulatory domain relative to the carrier domain were modeled in 
order to construct a model for the entire APC1 protein48 and each was energy-minimised using the MODELLER 
web server49. The highest scoring model was used as a reference structure and run with the I-TASSER web 
server47, specifying distance restraints once again. Some manual improvements were made to output models to 
improve distances between interacting residues, for example selecting correct side-chain rotamers48. The final dis-
tances between interacting residues are displayed in (Supplementary Table 1). It should be noted that all models 
positioned the amphipathic α -helix close to the cavity of the carrier domain consistent with the proposal that it 
interacts with the carrier domain in a locking-pin mechanism, but the highest scoring model was chosen in order 
to represent the full-length protein.
The final model has been submitted to the protein model database under accession code: PM0080481.
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